A new report titled “BCG Vaccine Market – Forecast to 2033” by Eternal Markets, the global BCG Vaccine industry is projected to grow at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2033, reaching a value of USD 158.7 million by the end of the forecast period.
Overview
The Bacillus Calmette–Guérin (BCG) vaccine, primarily used to prevent tuberculosis (TB), has been a cornerstone in global public health initiatives for decades. As of 2023, the global BCG vaccine market is experiencing significant growth due to increased awareness and rising incidence of TB, particularly in developing countries. With an estimated CAGR of around 4.8% over the forecast period from 2024 to 2033, the market size is projected to reach USD 158.7 million by 2033 from USD 95.5 million in 2023. Key factors driving this growth include improved healthcare infrastructure, government initiatives, and the increasing prevalence of TB.
Key Visions
- Market Size and Growth: The global BCG vaccine market is expected to grow from USD 95.5 million in 2023 to USD 158.7 million by 2033, at a CAGR of 4.8% during the forecast period.
- Key Drivers: Rising prevalence of tuberculosis, government immunization programs, and growing healthcare infrastructure.
- Leading Segment by Age Group: In 2023, the pediatrics segment held the largest market share.
- Leading Distribution Channel: Retail pharmacy segment is projected to be the largest revenue contributor by 2033.
- Regional Leader: Asia-Pacific held the largest market share in 2023, driven by high TB incidence and extensive immunization programs.
Key Market Drivers
Rising Incidence of Tuberculosis: The increasing number of TB cases worldwide, especially in developing regions, is driving the demand for the BCG vaccine.
Government Immunization Programs: National immunization programs and initiatives by global health organizations are significantly boosting market growth.
Advancements in Vaccine Technology: Innovations in vaccine formulations and delivery methods are enhancing the effectiveness and acceptance of the BCG vaccine.
Healthcare Infrastructure Improvements: Expanding healthcare infrastructure in emerging markets is facilitating wider distribution and administration of vaccines.
Increased Awareness and Education: Enhanced awareness and education about TB prevention are leading to higher vaccination rates.
Restraining Factors
Vaccine Hesitancy: Misinformation and lack of awareness about the benefits of the BCG vaccine can lead to lower vaccination rates.
Regulatory Challenges: Strict regulatory requirements and lengthy approval processes can delay the introduction of new vaccines.
Future Scope
The future of the BCG vaccine market appears promising, with several key trends expected to shape its growth trajectory:
Expansion in Emerging Markets: Rapid economic development and improved healthcare access in countries like India, China, and Brazil will drive market expansion.
Development of Enhanced Vaccines: Ongoing research and development efforts aimed at improving vaccine efficacy and safety will likely yield new product offerings.
Integration with Other Vaccines: Combining the BCG vaccine with other immunizations could streamline vaccination schedules and improve uptake.
Focus on Adult Vaccination: Increased attention to adult and booster vaccinations will open new market segments.
Digital Health Initiatives: Leveraging digital health technologies for tracking and monitoring vaccination programs will enhance efficiency and coverage.
Major Strategies adopted by key market players.
- Agreements, Collaborations, and Partnerships: 36%
- Acquisitions: 17%
- New Product Launch: _%
- Other Developments: _%
Geographical Analysis
North America: High healthcare expenditure, advanced infrastructure, and government initiatives position North America as a significant market for BCG vaccines.
Asia-Pacific: The region holds the largest market share due to the high prevalence of TB, extensive immunization programs, and improving healthcare infrastructure.
Recent Developments
- Mergers and Acquisitions: Sinovac acquired a local vaccine manufacturer to expand its market reach in Asia-Pacific.
- Partnerships and Collaborations: Serum Institute of India Pvt. Ltd. collaborated with WHO to distribute BCG vaccines in low-income countries.
- Industrial Advancements: Merck & Co., Inc. upgraded its manufacturing facilities to increase BCG vaccine production capacity.
- New Product Launch: AstraZeneca launched a combination vaccine that includes BCG and other childhood immunizations.
- Technological Achievement: Moderna Inc. announced advancements in mRNA vaccine technology applicable to TB.
Scope of the Report:
Global BCG Vaccine Market, By Vaccine Type
-
Subunit Vaccines
– Recombinant vaccines
– Conjugate vaccines
– Toxoid vaccines
-
Inactivated
-
Live attenuated
-
mRNA vaccines
-
Viral vector vaccines
Global BCG Vaccine Market, By Age Group
- Pediatrics (0-18 Years)
- Adults (19-35 Years)
Global BCG Vaccine Market, By Indication
-
Viral Diseases
– Hepatitis
– Influenza
– HPV
– MMR
– Rotavirus
– Herpes Zoster
– Covid-19
– Others
-
Bacterial Vaccines
– Meningococcal Diseases
– Pneumococcal diseases
– DPT
– Others
-
Cancer Vaccines
-
Allergy Vaccines
Global BCG Vaccine Market, By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global BCG Vaccine Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
● Serum Institute of India Pvt. Ltd.
● Seqirus
● Sanofi
● GSK Plc.
● Merck & Co., Inc.
● Pfizer Inc.
● Moderna Inc.
● Sinovac
● BioNTech SE
● AstraZeneca
● Microgen
● Japan BCG Laboratory
● Other key players
*The report scope shall be customized as per the requirements
Chapter 1 Global BCG Vaccine Market Overview
1.1 Introduction
1.2 Drivers for BCG Vaccine Market
1.3 Restraints for BCG Vaccine Market
1.4 Opportunities for BCG Vaccine Market
1.5 Trends for BCG Vaccine Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global BCG Vaccine Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Serum Institute of India Pvt. Ltd.
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Seqirus
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Sanofi
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 GSK Plc.
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Merck & Co., Inc.
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Pfizer Inc.
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Moderna Inc.
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Sinovac
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 BioNTech SE
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 AstraZeneca
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global BCG Vaccine Market Overview
3.1 Global BCG Vaccine Market Outlook (2017-2032)
3.1.1 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global BCG Vaccine Market by Region
3.2.1 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
3.3 Global BCG Vaccine Market by Vaccines Type
3.3.1 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2032)
3.3.2 Global BCG Vaccine Market Attractiveness Analysis by Vaccines Type, 2023–2032
3.3.3 Global BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
3.4 Global BCG Vaccine Market by Indication
3.4.1 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2032)
3.4.2 Global BCG Vaccine Market Attractiveness Analysis by Indication, 2023–2032
3.5 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Vaccines Type
3.6.1 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2023)
3.6.2 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2024-2032)
3.7 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Indication
3.7.1 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2023)
3.7.2 Global BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2024-2032)
3.8 Global BCG Vaccine Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global BCG Vaccine Market Y-o-Y Growth Rate by Region
3.8.2 Global BCG Vaccine Market Y-o-Y Growth Rate by Vaccines Type
3.8.3 Global BCG Vaccine Market Y-o-Y Growth Rate by Indication
3.9 Global BCG Vaccine Market Share Comparison 2017–2032
3.9.1 Global BCG Vaccine Market Share by Region
3.9.2 Global BCG Vaccine Market Share by Vaccines Type
3.9.3 Global BCG Vaccine Market Share by Indication
Chapter 4 North America BCG Vaccine Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America BCG Vaccine Market Outlook (2017-2032)
4.2.1 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America BCG Vaccine Market by Region
4.3.1 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
4.4 North America BCG Vaccine Market by Vaccines Type
4.4.1 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2032)
4.4.2 North America BCG Vaccine Market Attractiveness Analysis by Vaccines Type, 2023–2032
4.4.3 North America BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
4.5 North America BCG Vaccine Market by Indication
4.5.1 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2032)
4.5.2 North America BCG Vaccine Market Attractiveness Analysis by Indication, 2023–2032
4.6 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Vaccines Type
4.7.1 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2023)
4.7.2 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2024-2032)
4.8 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Indication
4.8.1 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2023)
4.8.2 North America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2024-2032)
4.9 North America BCG Vaccine Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America BCG Vaccine Market Y-o-Y Growth Rate by Region
4.9.2 North America BCG Vaccine Market Y-o-Y Growth Rate by Vaccines Type
4.9.3 North America BCG Vaccine Market Y-o-Y Growth Rate by Indication
4.1 North America BCG Vaccine Market Share Comparison 2017–2032
4.10.1 North America BCG Vaccine Market Share by Region
4.10.2 North America BCG Vaccine Market Share by Vaccines Type
4.10.3 North America BCG Vaccine Market Share by Indication
Chapter 5 Europe BCG Vaccine Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe BCG Vaccine Market Outlook (2017-2032)
5.2.1 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe BCG Vaccine Market by Region
5.3.1 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe BCG Vaccine Market by Vaccines Type
5.4.1 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2032)
5.4.2 Europe BCG Vaccine Market Attractiveness Analysis by Vaccines Type, 2023–2032
5.4.3 Europe BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe BCG Vaccine Market by Indication
5.5.1 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2032)
5.5.2 Europe BCG Vaccine Market Attractiveness Analysis by Indication, 2023–2032
5.6 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Vaccines Type
5.7.1 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2023)
5.7.2 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2024-2032)
5.8 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Indication
5.8.1 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2023)
5.8.2 Europe BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2024-2032)
5.9 Europe BCG Vaccine Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe BCG Vaccine Market Y-o-Y Growth Rate by Region
5.9.2 Europe BCG Vaccine Market Y-o-Y Growth Rate by Vaccines Type
5.9.3 Europe BCG Vaccine Market Y-o-Y Growth Rate by Indication
5.1 Europe BCG Vaccine Market Share Comparison 2017–2032
5.10.1 Europe BCG Vaccine Market Share by Region
5.10.2 Europe BCG Vaccine Market Share by Vaccines Type
5.10.3 Europe BCG Vaccine Market Share by Indication
Chapter 6 Asia Pacific BCG Vaccine Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific BCG Vaccine Market Outlook (2017-2032)
6.2.1 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific BCG Vaccine Market by Region
6.3.1 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific BCG Vaccine Market by Vaccines Type
6.4.1 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2032)
6.4.2 Asia Pacific BCG Vaccine Market Attractiveness Analysis by Vaccines Type, 2023–2032
6.4.3 Asia Pacific BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific BCG Vaccine Market by Indication
6.5.1 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2032)
6.5.2 Asia Pacific BCG Vaccine Market Attractiveness Analysis by Indication, 2023–2032
6.6 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Vaccines Type
6.7.1 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2023)
6.7.2 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2024-2032)
6.8 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Indication
6.8.1 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2023)
6.8.2 Asia Pacific BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2024-2032)
6.9 Asia Pacific BCG Vaccine Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific BCG Vaccine Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific BCG Vaccine Market Y-o-Y Growth Rate by Vaccines Type
6.9.3 Asia Pacific BCG Vaccine Market Y-o-Y Growth Rate by Indication
6.1 Asia Pacific BCG Vaccine Market Share Comparison 2017–2032
6.10.1 Asia Pacific BCG Vaccine Market Share by Region
6.10.2 Asia Pacific BCG Vaccine Market Share by Vaccines Type
6.10.3 Asia Pacific BCG Vaccine Market Share by Indication
Chapter 7 South America BCG Vaccine Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America BCG Vaccine Market Outlook (2017-2032)
7.2.1 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America BCG Vaccine Market by Region
7.3.1 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
7.4 South America BCG Vaccine Market by Vaccines Type
7.4.1 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2032)
7.4.2 South America BCG Vaccine Market Attractiveness Analysis by Vaccines Type, 2023–2032
7.4.3 South America BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
7.5 South America BCG Vaccine Market by Indication
7.5.1 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2032)
7.5.2 South America BCG Vaccine Market Attractiveness Analysis by Indication, 2023–2032
7.6 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Vaccines Type
7.7.1 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2023)
7.7.2 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2024-2032)
7.8 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Indication
7.8.1 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2023)
7.8.2 South America BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2024-2032)
7.9 South America BCG Vaccine Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America BCG Vaccine Market Y-o-Y Growth Rate by Region
7.9.2 South America BCG Vaccine Market Y-o-Y Growth Rate by Vaccines Type
7.9.3 South America BCG Vaccine Market Y-o-Y Growth Rate by Indication
7.1 South America BCG Vaccine Market Share Comparison 2017–2032
7.10.1 South America BCG Vaccine Market Share by Region
7.10.2 South America BCG Vaccine Market Share by Vaccines Type
7.10.3 South America BCG Vaccine Market Share by Indication
Chapter 8 Middle East and Africa BCG Vaccine Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa BCG Vaccine Market Outlook (2017-2032)
8.2.1 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa BCG Vaccine Market by Region
8.3.1 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa BCG Vaccine Market by Vaccines Type
8.4.1 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2032)
8.4.2 Middle East and Africa BCG Vaccine Market Attractiveness Analysis by Vaccines Type, 2023–2032
8.4.3 Middle East and Africa BCG Vaccine Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa BCG Vaccine Market by Indication
8.5.1 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2032)
8.5.2 Middle East and Africa BCG Vaccine Market Attractiveness Analysis by Indication, 2023–2032
8.6 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Vaccines Type
8.7.1 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2017-2023)
8.7.2 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Vaccines Type (2024-2032)
8.8 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) by Indication
8.8.1 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2017-2023)
8.8.2 Middle East and Africa BCG Vaccine Market Value (US$ Mn) and Volume (Units) Comparison by Indication (2024-2032)
8.9 Middle East and Africa BCG Vaccine Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa BCG Vaccine Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa BCG Vaccine Market Y-o-Y Growth Rate by Vaccines Type
8.9.3 Middle East and Africa BCG Vaccine Market Y-o-Y Growth Rate by Indication
8.1 Middle East and Africa BCG Vaccine Market Share Comparison 2017–2032
8.10.1 Middle East and Africa BCG Vaccine Market Share by Region
8.10.2 Middle East and Africa BCG Vaccine Market Share by Vaccines Type
8.10.3 Middle East and Africa BCG Vaccine Market Share by Indication
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources